Insider Trading Alert - HNT, MA And GRPN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 23, 2014, 39 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $250.00 to $78,529,267.63.

Highlighted Stocks Traded by Insiders:

Health Net (HNT) - FREE Research Report

Yeager Frederick C, who is Director at Health Net, sold 4,000 shares at $47.69 on Sept. 23, 2014. Following this transaction, the Director owned 17,175 shares meaning that the stake was reduced by 18.89% with the 4,000-share transaction.

Tough Steven D, who is Pres, Govt Progrms at Health Net, sold 10,000 shares at $46.90 on Sept. 23, 2014. Following this transaction, the Pres, Govt Progrms owned 95,669 shares meaning that the stake was reduced by 9.46% with the 10,000-share transaction.

The shares most recently traded at $45.81, down $1.09, or 2.38% since the insider transaction. Historical insider transactions for Health Net go as follows:

  • 4-Week # shares sold: 35,473
  • 12-Week # shares sold: 35,473
  • 24-Week # shares sold: 35,473

The average volume for Health Net has been 934,100 shares per day over the past 30 days. Health Net has a market cap of $3.7 billion and is part of the health care sector and health services industry. Shares are up 54.47% year-to-date as of the close of trading on Tuesday.

Health Net, Inc. provides managed health care services through health plans and government-sponsored managed care plans in the United States. It operates through Western Region Operations and Government Contracts segments. The company has a P/E ratio of 15.8. Currently, there are 3 analysts who rate Health Net a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HNT - FREE

TheStreet Quant Ratings rates Health Net as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Health Net Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Justice Department Probing Health Insurers Over Medicare Fraud Allegations

Health Net (HNT) Stock Gains on Centene Acquisition Regulatory Approval

Health Net, Centene Merger Faces California Scrutiny

Barbarian At The Gate: Health Net (HNT)

Trade-Ideas: Health Net (HNT) Is Today's "Dead Cat Bounce" Stock